N-(2,3-dichlorophenyl)cyclohexanecarboxamide

N-(2,3-dichlorophenyl)cyclohexanecarboxamide Suppliers list
Company Name: Energy Chemical  
Tel: 400-0056266
Email: marketing1@energy-chemical.com
Company Name: Jinan Jiuli Biotechnology Co. , Ltd.  
Tel: 15865264761
Email: 486064515@qq.com
Company Name: Shaoguan Qicheng Biotechnology Co., Ltd  
Tel: 18122215013
Email: 780229652@qq.com
Company Name: TargetMol  
Tel: 400-821-0310 15002144251
Email: xuexiang.shao@tsbiochem.com
N-(2,3-dichlorophenyl)cyclohexanecarboxamide Basic information
Product Name:N-(2,3-dichlorophenyl)cyclohexanecarboxamide
Synonyms:N-(2,3-dichlorophenyl)cyclohexanecarboxamide;MJC13;Cyclohexanecarboxamide, N-(2,3-dichlorophenyl)-;MJC13 >=98% (HPLC)
CAS:200709-97-3
MF:C13H15Cl2NO
MW:272.17
EINECS:
Product Categories:
Mol File:200709-97-3.mol
N-(2,3-dichlorophenyl)cyclohexanecarboxamide Structure
N-(2,3-dichlorophenyl)cyclohexanecarboxamide Chemical Properties
Boiling point 429.3±35.0 °C(Predicted)
density 1.302±0.06 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: ≥10mg/mL
pka13.40±0.70(Predicted)
form powder
color white to beige
Safety Information
Hazard Codes Xn
Risk Statements 22-36
Safety Statements 26
WGK Germany 3
MSDS Information
N-(2,3-dichlorophenyl)cyclohexanecarboxamide Usage And Synthesis
UsesMJC13 is an FKBP52-targeted agent with anti-tumor activity that can be used in prostate cancer research[1].
References[1] Su Liang, et al. Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2016;21(1):121-6. DOI:10.3109/10837450.2014.979946
N-(2,3-dichlorophenyl)cyclohexanecarboxamide Preparation Products And Raw materials
Tag:N-(2,3-dichlorophenyl)cyclohexanecarboxamide(200709-97-3) Related Product Information
dTAGV-1 Rapamycin RapaBlock RC32 Ascomycin SAFit1